Skip to content

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

A Prospective, Single Center, Observational Study Comparing the Safety and Efficacy of CVATS, HVATS and Open Surgery for Subjects Diagnosed With NSCLC Scheduled to Undergo a Lobectomy

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00912366
Enrollment
39
Registered
2009-06-03
Start date
2009-05-31
Completion date
2010-12-31
Last updated
2015-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Keywords

VATS, Lung cancer, NSCLC

Brief summary

Assessment of VATS versus standard open surgery for treatment of non small cell lung cancer.

Interventions

PROCEDURELobectomy

Assessment of VATS versus open surgery.

Sponsors

Medtronic - MITG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be 18 years of age or older. * Subject must have been clinically diagnosed with stage I to stage IIA non small cell lung cancer measuring and judged to be resectable. * Subject must be able to tolerate general anesthesia, and have cardiopulmonary reserve to tolerate a lobectomy

Exclusion criteria

* Subject is pregnant (documented by pregnancy test) or breastfeeding. * Subject has other severe illnesses that would preclude surgery such as * Unstable angina * Myocardial Infarction within 3 months * Coronary Artery Bypass Graft Surgery * Subject has other active cancers * Subject is unable to comply with any of the following: * Study requirements * Give valid informed consent * Follow-up schedule

Design outcomes

Primary

MeasureTime frame
Assess hospital length of stay (LOS).1 time point (discharge)
Pain Scale Evaluation5 time points out to 6 months

Secondary

MeasureTime frame
Assess quality of life.2 time points out to 6 months
Assess peri-operative and post-operative complications.5 time points out to 6 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026